Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Joan Cox Gill
Creating a DDAVP Releasable Pool of Factor VIII: Its Impact on the Gene Therapy of Hemophilia a † 786
Pediatric Research
Child Health
Pediatrics
Perinatology
Related publications
244. Factor VIII Immunogenicity Is a Barrier to AAV Gene Therapy for Hemophilia A
Molecular Therapy
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Lentivirus-Mediated Platelet Gene Therapy of Murine Hemophilia a With Pre-Existing Anti-Factor VIII Immunity
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Generation of an Optimized Lentiviral Vector Encoding a High-Expression Factor VIII Transgene for Gene Therapy of Hemophilia A
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
Improving the Performance of Factor VIII Inhibitor Tests in Hemophilia A
Thrombosis Research
Hematology
Postpartum Acquired Hemophilia Factor VIII �nhibitors and Response to Therapy
Turkish Journal of Haematology
Hematology
Effect of Route of Administration of Human Recombinant Factor VIII on Its Immunogenicity in Hemophilia a Mice
Journal of Pharmaceutical Sciences
Pharmaceutical Science
Immune Tolerance Induced by Platelet-Targeted Factor VIII Gene Therapy in Hemophilia a Mice Is CD4 T Cell-Mediated
Journal of Thrombosis and Haemostasis
Medicine
Hematology
Expression of Human Coagulation Factor VIII in Adipocytes Transduced With the Simian Immunodeficiency Virus agmTYO1-based Vector for Hemophilia a Gene Therapy
Gene Therapy
Molecular Medicine
Genetics
Molecular Biology
The Impact of Factor VIII/von Willebrand Factor Products in Inhibitor Development and Management of Patients With Hemophilia a With Inhibitors
Oncology & Hematology Review (US)